Treatment of Migraine in a 12-Year-Old
Start with ibuprofen 10 mg/kg at the earliest onset of headache as first-line acute treatment, and consider bed rest alone for short-duration attacks before any medication. 1
Acute Treatment Algorithm
First-Line Therapy
- Ibuprofen 10 mg/kg is the recommended first-line medication for acute migraine treatment in children, as established by the American Academy of Neurology. 1
- Alternatively, naproxen or acetaminophen (15 mg/kg) can be used if ibuprofen is contraindicated or ineffective. 2, 3
- Administer medication at the earliest onset of headache for maximum efficacy—waiting reduces treatment success. 1
- For very short-duration attacks, bed rest alone may suffice before initiating any pharmacotherapy. 1
When NSAIDs Fail
- Triptans have NOT been proven effective in children under 12 years old due to high placebo response rates in clinical trials. 1, 4
- The FDA has not approved oral sumatriptan for pediatric patients, and safety/effectiveness have not been established in those under 18 years. 5
- For adolescents 12-17 years, sumatriptan nasal spray (5-20 mg) and zolmitriptan nasal spray are the most effective triptan formulations, though evidence remains limited at age 12. 4, 2
Adjunctive Treatment
- Add an antiemetic if nausea or vomiting is prominent, though this recommendation is based on clinical practice rather than pediatric-specific evidence. 4
- Domperidone can be used for nausea in adolescents aged 12-17 years, though oral administration is unlikely to prevent vomiting. 4
Critical Contraindications
- Absolutely avoid opioids and butalbital—these cause medication overuse headache and dependency. 1
- Never use more than 10 days per month of acute medication to prevent medication overuse headache. 4
When to Consider Preventive Treatment
Refer to specialist care if acute medication provides insufficient pain relief. 1
Indications for Prevention
- Headaches occurring more than once per week. 6
- Prolonged or disabling attacks despite optimized acute treatment. 6
- Adverse impact on quality of life on ≥2 days per month despite acute treatment. 4
Preventive Medication Options
- Propranolol, amitriptyline, or topiramate are used in clinical practice for pediatric migraine prevention, though their effectiveness has not been proven in pediatric clinical trials. 4, 1
- The evidence base is confounded by high placebo response rates in children, resulting in low therapeutic gain. 4
- Approximately two-thirds of pediatric migraine patients improve with studied therapies, but one-third require more aggressive management. 4
Essential Lifestyle Modifications
Address lifestyle factors as they are critical predisposing elements:
- Ensure adequate and consistent sleep patterns—irregular sleep is a major migraine trigger. 1
- Maintain adequate fluid intake throughout the day. 1
- Prevent hypoglycemia with regular meals—skipping meals triggers attacks. 1
- Identify and avoid specific triggers through headache diary tracking. 6
Family and School Involvement
Clinical management requires active help from family members and teachers:
- Educate both parents and teachers about migraine characteristics and management strategies. 4, 1
- Parents provide more reliable symptom descriptions than young children, particularly regarding pain quality and associated features. 4, 1
- Explain that migraine attacks in children are often shorter in duration, bilateral (not unilateral), and more frontal than in adults. 4, 1
- Gastrointestinal symptoms are commonly prominent in pediatric migraine. 4
Common Pitfalls to Avoid
- Do not delay treatment—early medication administration is crucial for efficacy. 1
- Do not use triptans as first-line therapy in a 12-year-old given lack of proven efficacy and FDA approval concerns. 1, 5
- Do not prescribe valproate to females of childbearing age due to teratogenic risk. 4
- Monitor for medication overuse—frequent acute medication use can transform episodic migraine into chronic daily headache. 4
- Do not skip neuroimaging evaluation if red flags are present: occipital location, inability to describe pain, focal neurological signs, thunderclap onset, or fever with neurological signs. 1